America’s hospitals and health systems are committed to protecting patients from unanticipated medical bills that they may incur because of gaps in their insurance coverage or as a result of emergencies. Unfortunately, unless this proposal is much improved over previous bills that rely on a benchmark rate, it remains highly problematic and would jeopardize patient access to hospital care, particularly in rural communities.
Below are the most recent press releases from the American Hospital Association.
Hospital Groups File Lawsuit Over Illegal Rule Mandating Public Disclosure of Individually Negotiated RatesDec 3, 2019
Nov 21, 2019
Joint Statement from National Hospital and Health System Groups on Public Disclosure of Privately Negotiated Rates Final RuleNov 15, 2019
The American Hospital Association (AHA), Association of American Medical Colleges (AAMC), Children’s Hospital Association (CHA) and Federation of American Hospitals (FAH) issued the following joint statement on today’s final rule from CMS: Today’s rule mandating the public disclosure of privately negotiated rates between commercial health insurance companies and hospitals is a setback in efforts to provide patients with the most relevant information they need to make informed decisions about their care.
Nov 14, 2019
Nov 13, 2019
Nov 11, 2019
The field has lost a giant in health care. Bernard Tyson was a champion for creating a more integrated and coordinated delivery system, and expanding coverage and access.
Nov 1, 2019
Today’s final rule from CMS regrettably ignores recent legal decisions while also putting even more pressure on hospitals and health systems that care for vulnerable patients and communities.
Nov 1, 2019
The AHA welcomes the nomination of Dr. Stephen Hahn, a renowned oncologist and physician leader, to be the next commissioner of the Food and Drug Administration. As the chief medical executive at The University of Texas MD Anderson Cancer Center, Dr. Hahn leads the medical practice at one of the world’s top hospitals devoted to cancer care, research, education and prevention. We believe that Dr. Hahn’s more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.